Delivery Order SPE2DB22D3004-SPE2DB25FPT43

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,642.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of November 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a for-profit organization registered in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,771.65 firm fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract has an ultimate completion date of January 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,187.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Tresiba Flextouch 200 unit/ml 3ml, a prescription medication used to manage diabetes. The award has a firm fixed price pricing type and an ultimate completion date of June 22, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,076.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical supply product, with a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,854.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Tresiba Flextouch 200 unit/mL 3mL, a prescription medication, with a completion date of July 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $4,047.48, is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,410.78, is for the delivery of Tresiba FlexTouch insulin products. It is a firm-fixed-price delivery order contract with a completion date of December 20, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,652.15 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 29, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,000.83 Firm Fixed Price delivery order is for the supply of Tresiba FlexTouch 100 unit/mL 3mL, a medication used for diabetes management. The contract has a completion date of January 10, 2023 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $7,173.22 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) for the supply of Tresiba Flextouch 200 unit/mL 3mL medication. The contract has an ultimate completion date of April 26, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPT43
    Delivery Order

This federal contract award, valued at $3,737.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/2/25, 9:58 AM